These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6272994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M, Dickgiesser N, Müller S, Wundt W.
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [Abstract] [Full Text] [Related]

  • 3. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 4. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB.
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A, Fantin B.
    Minerva Med; 1983 Mar 10; 74(9-10):427-31. PubMed ID: 6300736
    [Abstract] [Full Text] [Related]

  • 7. [Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative data with other beta-lactamic antibiotics].
    Mascellino MT, Prignano G, Iegri F, Delia S.
    Boll Ist Sieroter Milan; 1981 May 10; 60(2):102-9. PubMed ID: 6272823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E, Marone P, Verani D, Marino P.
    Boll Ist Sieroter Milan; 1982 May 10; 61(4):300-8. PubMed ID: 6100233
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F, Fernández-Cuenca F, Pachón-Ibáñez ME, Pascual A, Pichardo C, Martínez-Martínez L, Pachón J.
    Clin Microbiol Infect; 2008 Jun 10; 14(6):582-7. PubMed ID: 18294246
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system].
    Concia E, Marone P, Dos Santos C, Bono L.
    Quad Sclavo Diagn; 1982 Jun 10; 18(2):223-32. PubMed ID: 6300953
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M, Grehn M, Wundt W.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun 10; 252(2):208-21. PubMed ID: 6289564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.